Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine β-thalassemia
Year: 2014
Type: article
Source: Blood
Institutions: Acceleron Pharma (United States), Weill Cornell Medicine
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2151573971
